Med Life S.A.

BVB:M Rapport sur les actions

Capitalisation boursière : RON 3.2b

Med Life Gestion

Gestion contrôle des critères 2/4

Le PDG Med Life est Mihail Marcu, nommé en Dec2016, a un mandat de 18.33 ans. détient directement 14.78% des actions de la société, d'une valeur de RON 470.91M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 7.3 ans et 8 ans.

Informations clés

Mihail Marcu

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général8yrs
Propriété du PDG14.8%
Durée moyenne d'occupation des postes de direction7.3yrs
Durée moyenne du mandat des membres du conseil d'administration8yrs

Mises à jour récentes de la gestion

Recent updates

Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

Aug 06
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Jun 08
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Is Med Life (BVB:M) A Risky Investment?

Apr 05
Is Med Life (BVB:M) A Risky Investment?

Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Jul 05
Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Is Med Life (BVB:M) A Risky Investment?

Jan 06
Is Med Life (BVB:M) A Risky Investment?

Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

Dec 06
Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Sep 27
We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Returns Are Gaining Momentum At Med Life (BVB:M)

May 05
Returns Are Gaining Momentum At Med Life (BVB:M)

Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Mar 01
Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Jan 22
Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Aug 31
Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Med Life's (BVB:M) Returns On Capital Are Heading Higher

Jun 10
Med Life's (BVB:M) Returns On Capital Are Heading Higher

Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

May 26
Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

May 12
Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Apr 12
Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Mar 16
Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Mar 04
Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Feb 20
Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Feb 07
Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Jan 25
Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Jan 08
Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Dec 23
Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

Dec 08
Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

The Trends At Med Life (BVB:M) That You Should Know About

Nov 24
The Trends At Med Life (BVB:M) That You Should Know About

PDG

Mihail Marcu (54 yo)

8yrs

Titularisation

Mr. Mihail Marcu serves as Chief Executive Officer at S.C. Med Life S.A. since December 2016. Mr. Marcu served as the Chief Executive Officer of MedLife between January 2004 until August 2006 and vice pres...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Mihail Marcu
Chairman & CEO8yrspas de données14.78%
RON 470.9m
Alina Irinoiu
CFO & Investor Relations Manager2.3yrspas de donnéespas de données
Nicolae Marcu
Chief Healthcare & Operations Officer and Directorno datapas de données10.42%
RON 332.0m
Vera Firu
Accounting & Tax Directorno datapas de donnéespas de données
Radu Petrescu
Human Resources Director7.3yrspas de donnéespas de données
Mirela Dogaru
Commercial Directorno datapas de donnéespas de données
Dorin Preda
Chief Financeno datapas de donnéespas de données

7.3yrs

Durée moyenne de l'emploi

51yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de M est chevronnée et expérimentée (7.3 années d'ancienneté moyenne).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Mihail Marcu
Chairman & CEO18.3yrspas de données14.78%
RON 470.9m
Nicolae Marcu
Chief Healthcare & Operations Officer and Director8yrspas de données10.42%
RON 332.0m
Dorin Preda
Chief Finance16.9yrspas de donnéespas de données
Ovidiu Fer
Independent Director4yrspas de donnéespas de données
Ana Mihaescu
Independent Director7.3yrspas de donnéespas de données
Dimitrie Pelinescu-Onciul
Director16.9yrspas de donnéespas de données
Voicu Cheta
Independent Director4yrspas de donnéespas de données

8.0yrs

Durée moyenne de l'emploi

54yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de M sont considérés comme expérimentés (ancienneté moyenne 8 ans).